1<!DOCTYPE html>
2
3Anonymous
4/bestp
5/bestp/domrep.nsf
6F9F6C7BCF94EB26465257D080045E09F
8
9
10
11
12
13
140
15
16
17/bestp/domrep.nsf/products/patient-focused-support-how-govt-affairs&public-policygroups-support-the-patient-journey
18
19
2054.226.73.255
21
22
23www.best-in-class.com
24/bestp/domrep.nsf
25BMR




» Products & Services » » Medical Affairs » Patient Advocacy

Patient-Focused Support: How Government Affairs & Public Policy Groups Support the Patient Journey

ID: PSM-307


Features:

8 Info Graphics

12 Data Graphics

100 Metrics

3 Narratives


Pages: 31


Published: 2014


Delivery Format: Shipped


 

License Options:
close

Single User: Authorizes use by the person who places the order or for whom the order was placed.

Sitewide: Authorizes use of the report for a geographic site. All people at site can view the report for a year and copies can be printed.

Corporate: Authorizes use for the entire company for a year and copies can be printed. No limitations for usage inside the company.




Buy Now

 

919-403-0251

  • STUDY OVERVIEW
  • BENCHMARK CLASS
  • STUDY SNAPSHOT
  • KEY FINDINGS
  • VIEW TOC AND LIST OF EXHIBITS
Patient advocacy is a critical success factor in the health care industry. Government Affairs and Public Policy functions provide various patient support programs and initiatives designed to engage patients.

Best Practices, LLC undertook this research study to capture industry metrics on the level and type of support that Government Affairs and Public Policy functions provide to positively impact the patient journey. The study includes leading insights and metrics around the activities, timing and funding contribution of Government Affairs and Public Policy groups towards patient advocacy and awareness.

Industries Profiled:
Pharmaceutical; Health Care; Biotech; Biopharmaceutical; Clinical Research; Laboratories; Chemical; Technology; Diagnostic; Medical Device


Companies Profiled:
Boehringer Ingelheim; Dr Reddy's Laboratories; GlaxoSmithKline ; Shire; Abbvie; Teva Pharmaceutical Industries Ltd; Sanofi; BD; UCB Pharma; Astellas; Janssen; AstraZeneca; Abbott; Genentech; Roche


Study Snapshot

Sixteen survey respondents from 15 companies participated in this study. The majority of study participants worked either at the director, senior director or vice president level. Almost all study participants worked in either Government Affairs or Public Policy roles.

Key topics include:

Patient-Focused Support: Activities & Timing
  • Scope
  • Number of Product Supported
  • Activities
  • Timing by Phase

Patient-Focused Support: Funding
  • Investment by Function
  • Investment Trends
  • Investment Levels

Key Findings

Partnering with patient advocacy groups is most common engagement activity: Partnering with patient advocacy groups occurs at 87% of benchmarked organizations, while 67% are also active in community outreach programs (e.g., screening events), and influencing payer & federal disease policy.

Table of Contents

Executive Summary    pp. 3-4 
  • Research Overview  pp. 4
  • Participating Companies                               pp. 5-6
Key Findings  pp. 7-10
Patient-Focused Support:  Activities & Timing  pp. 11-22
Patient-Focused Support:  Funding                    pp. 23-30
About Best Practices, LLC    pp. 31

List of Charts & Exhibits

Functional area represented by benchmark partners
  • Type of products for which Gov't Affairs/Public Policy (GA/PP) groups conduct patient engagement activities
  • Therapeutic areas represented by the Gov't Affairs/Public Policy groups
  • Number of products/brands supported by GA/PP groups
  • The 6 phases of the patient journey
  • Patient engagement activities and programs conducted by GA/PP groups
  • GA/PP patient engagement activities timing by patient journey phase
  • Investment level into engagement activities by patient journey phase
  • GA/PP patient engagement – Best Practices
  • Patient engagement activities funding from GA/PP function
  • % allocation of total GA/PP budget to patient engagement activities
  • Total GA/PP patient engagement investment
  • Functions/Groups investing in patient engagement activities